May 24
|
Trump Trade: Trump considers 50% tariff on EU, 25% on iPhones
|
May 23
|
Bayer Gets CHMP Nod for Eylea 8 mg in the EU for 2 Major Eye Diseases
|
May 23
|
Bayer’s Eylea set for longer treatment intervals to challenge Roche’s Vabysmo
|
May 23
|
OTC Markets Group Welcomes Bayer AG to OTCQX
|
May 21
|
Bayer Begins Phase I Study on BAY 3670549 in Atrial Fibrillation
|
May 20
|
Bayer reports FDA approved Jivi for use in pediatric patients 7 years and older
|
May 19
|
The Zacks Analyst Blog Highlights Bayer, Novo Nordisk, GSK, Merck and AbbVie
|
Apr 24
|
North Dakota enacts nation's first law shielding Roundup's maker from some cancer lawsuits
|
Apr 23
|
World Bank adds Bayer, Hyatt and other CEOs to private sector initiative
|
Apr 23
|
ConcertAI and Bayer to boost precision oncology with AI and ML insights
|
Feb 13
|
BridgeBio price target raised to $49 from $48 at Scotiabank
|
Jan 3
|
Bayer Secures End of Roundup Weedkiller Litigation in Australia
|
Jan 3
|
Bayer: Federal Court Brings an End to Roundup™ Litigation in Australia
|
Nov 8
|
Bayer wins FDA clearance for Medrad Centargo CT injection system
|
Nov 8
|
Stocks to watch next week: Burberry, SSE, Disney, Alibaba and AstraZeneca
|
Oct 10
|
Bayer must pay $78 million in latest Roundup cancer trial, jury finds
|
Oct 10
|
Pharmaceutical Giant Bayer's Shares Plunge 7% as Washington Supreme Court Reopens PCB Case
|
Oct 9
|
Bayer Shares Plunge After U.S. Legal Setback
|
Oct 8
|
Bayer and MOMA Therapeutics partner for oncology programme
|
Oct 8
|
Zacks Industry Outlook Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer
|